Insider trade

Director received an award of 560.9 BMY derivative securities

Traded Sep 30, 2026 · Filed Oct 3, 2026

Bristol Myers SquibbBMY

560.9
Derivative units · @ $62.40

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Sep 30, 2026
Reporting period: Not applicable
Filed with the SEC: Oct 3, 2026

DirectorGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001269070-26-000011
Filed / recorded

Oct 3, 2026, 12:26 AM UTC

Added to OQRO

Oct 3, 2026, 11:40 AM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

BRISTOL MYERS SQUIBB CO

Issuer CIK

14272

Ticker

BMY

Reporting person

Phyllis R Yale

Relationship

Director

Security

Deferred Share Units

Table

Derivative (Table II)

Transaction date

Sep 30, 2026

Transaction code

A

Shares / units

560.897

Price per share

$62.40

Acquired / disposed

Acquired (A)

Shares owned after

45,980.077

Ownership form

Direct

Amendment

No

Footnotes from the filing

Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.
Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.